Stockreport

Nkarta to Participate in March Investor Conferences [Yahoo! Finance]

Nkarta, Inc.  (NKTX) 
PDF company developing engineered natural killer (NK) cell therapies to treat autoimmune diseases, today announced its participation in the following investor conferences: [Read more]